Panbela Therapeutics, Inc.

Ticker PBLA

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

1-10 Employees
Based in Waconia, Minnesota

Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for patients with urgent unmet medical needs. Panbela’s lead assets are Ivospemin (SBP-101) and Flynpovi. Panbela’s common stock is listed on The Nasdaq Stock Market LLC under the symbol “PBLA”.

Visit website

REPORT RATINGS

5.0 / 5.0 (1)

Panbela Therapeutics, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Panbela Therapeutics, Inc.